What we look for in a project

Projects suitable for our portfolio would typically be ready for identification or optimisation of chemical starting points, and meet a number of the following criteria:

  • Aimed at either disease-modifying or symptomatic treatments.

  • Represent emerging or neglected areas rather than those already well supported.

  • Have robust validation of the relevance of the biological pathway to the proposed indication, such as, for example, a genetic link or activity in a suitable in vivo model.

  • Include either assay formats suitable for a high-throughput screen to identify hits, or chemical starting points for optimisation.

  • Carry potential for generating novel intellectual property.

  • Generally possess a profile similar to projects that a private biotech would pursue.


If you have a project that is at the drug discovery or clinical development stage, it may be considered for the Parkinson's Virtual Biotech.

If you have a project that fits with our aims and would be interested in learning more about the opportunities for working together, we would be delighted to hear from you.

Our workshop